RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P37
Within normal range
vs 2Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -10.53% |
| Q2 2025 | 78.50% |
| Q1 2025 | -402.19% |
| Q4 2024 | 40.77% |
| Q3 2024 | 37.41% |
| Q2 2024 | -3.95% |
| Q1 2024 | 2.41% |
| Q4 2023 | -26.82% |
| Q3 2023 | 24.03% |
| Q2 2023 | -54.87% |
| Q1 2023 | 18.59% |
| Q4 2022 | -33.24% |
| Q3 2022 | -12.86% |
| Q2 2022 | 2.46% |
| Q1 2022 | 24.67% |
| Q4 2021 | -65.20% |
| Q3 2021 | 10.04% |
| Q2 2021 | -0.04% |
| Q1 2021 | 9.48% |
| Q4 2020 | -54.39% |
| Q3 2020 | -54.86% |
| Q2 2020 | 26.51% |
| Q1 2020 | -53.74% |
| Q4 2019 | 53.14% |
| Q3 2019 | -34.68% |
| Q2 2019 | -4.39% |
| Q1 2019 | 6.26% |
| Q4 2018 | -3.93% |
| Q3 2018 | -22.05% |
| Q2 2018 | 4.66% |
| Q1 2018 | 0.00% |